Diagnostic and therapeutic methods of inflammatory bowel disease

systematic review

Authors

  • Gabriel Veríssimo Neves de Barros Centro Universitário Metropolitano da Amazônia
  • Thaís Sant’Ana Soares Silva Centro Universitário Metropolitano da Amazônia
  • Ana Paula de Santos Oliveira Brito Centro Universitário Metropolitano da Amazônia
  • Hamilton Cezar Rocha Garcia Centro Universitário Metropolitano da Amazônia
  • Rodrigo Bona Maneschy Centro Universitário Metropolitano da Amazônia

DOI:

https://doi.org/10.4322/prmj.2019.042

Keywords:

ulcerative colitis, Crohn`s Disease, management, treatment

Abstract

Objective: To carry out a systematic review of articles published in the last decade, aiming at research on diagnostic and therapeutic methods of inflammatory bowel diseases. Method: Studies published from 2014 to 2019 were selected. The keywords used were “Ulcerative Colitis”, “Crohn’s Disease”, “Diagnosis” and “Therapeutics”. The databases consulted were MedLine, SciELO and Science Direct. Results: 102 articles were selected, in which 92 of them met the exclusion criteria, leaving ten articles within the inclusion criteria, where three articles were taken from MedLine, three from SciELO and four from Science Direct, in Spanish (1), Portuguese (1) and English (8). Seven articles were found on both IBD (Ulcerative Colitis and Chron’s Disease), one article only on Ulcerative Colitis and two articles only on Chron’s Disease, with six articles citing diagnostic methods of Ulcerative Colitis and eight reported therapeutic alternatives, while seven articles analyzed diagnostic methods for Chron’s Disease and nine reported therapeutic options. Conclusion: Analysis of the literature shows that for the diagnosis of inflammatory bowel disease it is necessary that it be based on anamnesis and physical examination in an impeccable way, making it difficult to identify positive cases of the disease in its initial stages for a better prognosis of the patient. There is currently an acceptable amount of medication, the treatment is done only for remission of symptoms since there is currently no cure for inflammatory bowel disease and is based on various types of agents such as aminosalicylates, immunomodulators and biological agents. It is not yet possible to achieve a cure, as there is no complete understanding of the pathophysiology or even the functioning of some drugs currently used.

Downloads

Download data is not yet available.

Author Biographies

Gabriel Veríssimo Neves de Barros, Centro Universitário Metropolitano da Amazônia

Acadêmico de Medicina do Centro Universitário Metropolitano da Amazônia (UNIFAMAZ).

Thaís Sant’Ana Soares Silva, Centro Universitário Metropolitano da Amazônia

Acadêmica de Medicina do Centro Universitário Metropolitano da Amazônia (UNIFAMAZ).

Ana Paula de Santos Oliveira Brito, Centro Universitário Metropolitano da Amazônia

Médica formada pela Universidade Federal do Pará com residência em clínica médica e atuação em gastroenterologia clínica e motilidade digestiva. É professora e orientadora do curso de medicina da UNIFAMAZ.

Hamilton Cezar Rocha Garcia, Centro Universitário Metropolitano da Amazônia

Médico formado pela Universidade Federal do Pará com residência em cirurgia geral pelo Hospital Ophir Loyola.

Rodrigo Bona Maneschy, Centro Universitário Metropolitano da Amazônia

Médico formado pela Universidade do Estado do Pará - UEPA com mestrado em cirurgia e pesquisa experimental pela UEPA. É professor do
curso de medicina da UNIFAMAZ.

References

Bernstein CN, Eliakim A, Fedail S, Fried M, Gearry R, Goh KL, et al. World gastroenterology organisation global guidelines: inflammatory bowel disease update. J Clin Gastroenterol. 2015;50(10):803-18. http://dx.doi.org/10.1097/MCG.0000000000000660. PMid:27741097 .

Fakhoury M, Al-Salami H, Negrulj R, Mooranian A. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res. 2014;7:113- 20. http://dx.doi.org/10.2147/JIR.S65979 . PMid:25075198.

Yamamoto-Furusho JK, Bosques-Padilla F, de-Paula J, Galiano MT, Ibañez P, Juliao F, et al. Diagnóstico y tratamiento de la enfermedad inflamatoria intestinal: Primer Consenso Latinoamericano de la Pan American Crohn’s and Colitis Organisation. Rev Gastroenterol Mex. 2017;82(1):46-84. http://dx.doi.org/10.1016/j.rgmx.2016.07.003 . PMid:27979414.

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-54. http://dx.doi.org/10.1053/j.gastro.2011.10.001 . PMid:22001864.

Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17(1):423-39. http://dx.doi.org/10.1002/ibd.21349 .PMid:20564651.

Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158-165.e2. http://dx.doi.org/10.1053/j.gastro.2013.04.007 . PMid:23583432.

Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis. 2013;45(4):269-76. http://dx.doi.org/10.1016/j.dld.2012.08.020 . PMid:23010518.

Cecil RLF, Goldman L, Schafer AI. Goldman’s Cecil Medicine, Expert Consult Premium Edition - Enhanced Online Features and Print, Single Volume, 24: Goldman’s Cecil Medicine. Amsterdam: Elsevier Health Sciences; 2012.

Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Dig Liver Dis. 2013 Abr;45(4):269-76. http://dx.doi.org/10.1016/j.dld.2012.08.020 . PMid:23010518.

Burisch J. Crohn’s disease and ulcerative colitis. occurrence, course and prognosis during the first year of disease in a European population based inception cohort. Dan Med J. 2014;61(1):B4778 . PMid:24393595

Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, et al. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: The ECCO-EpiCom Cohort. Inflamm Bowel Dis. 2014;20(1):36-46. http://dx.doi.org/10.1097/01.MIB.0000436277.13917.c4 . PMid:24252978.

Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139(4):1147-55. http://dx.doi.org/10.1053/j.gastro.2010.06.070 . PMid:20637205.

Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741-55. http://dx.doi.org/10.1016/S0140-6736(16)31711-1 . PMid:27914655.

Costa AB, Zoltowski APC, Koller SH, Teixeira MAP. Construção de uma escala para avaliar a qualidade metodológica de revisões sistemáticas. Cien Saude Colet. 2015;20(8):2441-52. http://dx.doi.org/10.1590/1413-81232015208 . 10762014. PMid:26221809.

Su HJ, Chiu YT, Chiu CT, Lin YC, Wang CY, Hsieh JY, et al. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc. 2019;118(7):1083-92. http://dx.doi.org/10.1016/j.jfma.2018.07.005 . PMid:30054112.

Feuerstein JD, Cheifetz AS. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin Proc. 2014;89(11):1553-63. http://dx.doi.org/10.1016/j.mayocp.2014.07.002 . PMid:25199861.

Ho G-T, Lees C, Satsangi J. Ulcerative colitis. Curr Treat Options Gastroenterol. 2015;39(4):224-8. http://dx.doi.org/10.1016/j.mpmed.2011.01.005 . PMid:25619458.

Ray C, Sagar P. Management of Crohn’s disease and ulcerative colitis. Surgery. 2017;35(8):439-42. http://dx.doi.org/10.1016/j.mpsur.2017.06.001 .

Gajendran M, Loganathan P, Catinella AP, Hashash JG. A comprehensive review and update on Crohn’s disease. Dis Mon. 2018;64(2):20-57. http://dx.doi.org/10.1016/j.disamonth.2017.07.001 . PMid:28826742.

Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389(10080):1741-55. http://dx.doi.org/10.1016/S0140-6736(16)31711-1 . PMid:27914655.

Published

2020-06-29

How to Cite

Barros, G. V. N. de, Silva, T. S. S., Brito, A. P. de S. O., Garcia, H. C. R., & Maneschy, R. B. (2020). Diagnostic and therapeutic methods of inflammatory bowel disease: systematic review. Pará Research Medical Journal, 4, 1–6. https://doi.org/10.4322/prmj.2019.042

Issue

Section

Artigos de Revisão Sistemática